Feature | October 04, 2013

Latest IMV Market Report Shows Increased Cath Lab Purchase Activity Over Next Three Years

Cath lab IMV market report

October 4, 2013 — Purchasing activity for cardiac catheterization labs in the United States appears to be growing as more healthcare facilities look to replace aging equipment, according to a new report by IMV Medical Information Division. The census-based report finds that both patient volume and installed base are rising as the market recovers from a recent slowdown.

According to the report, patient volume has increased at a rate of 0.5 percent per year, and the number of identified fixed cath lab systems has increased at an average annual growth rate of 3.3 percent, from 4,225 units as of IMV’s 2008 census to 4,980 units in 2012. Going forward, an estimated 44 percent of surveyed cath lab sites are considering the purchase of cath lab units over the next three years to replace units or add rooms. This is likely due to several factors, including:

· An installed base of older units. The average replacement cycle is 11.1 years for sites that are planning to replace their units, which is up from 10 years in 2008. While cath lab facilities are holding on to their units longer, the peak years of cath lab installations occurred about a decade ago, so sites are replacing a larger number of aging units.

· Continued innovation and interest in using the cath lab rooms for minimally invasive procedures, including noncardiac procedures such as carotid, iliac, femoral, runoff, renal and extremity studies. Since 2000, the proportion of cath lab rooms being used for noncardiac cases has increased from 47 percent to 67 percent of rooms. In addition to diagnostic cardiologists and interventional radiologists, cardiothoracic surgeons and endovascular/vascular surgeons are performing procedures in cath lab settings.

· More than one-third of purchase plans are for adding fixed C-arms for use with cardiac and noncardiac procedures. In addition to adding units to the traditional cath lab or cardiology suites, at least 7 percent of sites are planning to locate their additional units in surgery/operating room (OR) departments.

An estimated 3.82 million patient cases were performed at 2,100 cardiac cath lab sites in 2012, including both cardiac and noncardiac patient cases. During the past decade, the total volume of patient cases peaked in 2006 at 4.21 million and declined to a low of 3.75 million in 2008. Since 2009, total patient volume has been relatively stable, increasing at an average annual growth rate of 0.5 percent.

“This slowdown in patient cases handled by cath labs is due to the convergence of several factors,” observed Lorna Young, senior director, Market Research at IMV. “With the advent of CT coronary angiography procedures (CTA), the volume of diagnostic cath procedures appears to have declined. In addition, the increased use of preauthorization policies by third party insurers may be at play.”

For more information: www.imvinfo.com

Related Content

LimFlow System, critical limb ischemia, CLI, CE Mark
News | Stents Peripheral| December 08, 2016
LimFlow SA announced in November that it received the CE Mark for its fully percutaneous LimFlow System designed for...
Sponsored Content | Videos | Angiography| December 07, 2016
Shimadzu's latest generation interventional lab angiography imaging system, the Trinias, enables advanced imaging cap
Lotus Edge valve
News | Heart Valve Technology| December 07, 2016
December 7, 2016 — Boston Scientific announced a definitive agreement to acquire certain manufacturing assets and cap
Impella CP, Abiomed
News | Hemodynamic Support Devices| December 07, 2016
December 7, 2016 — Abiomed Inc. announced it has expanded its U.S.
Vascular Solutions, Teleflex
Feature | December 07, 2016
December 7, 2016 — Teleflex Inc. and Vascular Solutions Inc.
Siemens Healthineers, PURE Platform, angiography, EVAR, CTO, RSNA 2016
News | Angiography| December 07, 2016
December 7, 2016 — At the 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America (
Spectranetics, Stellarex 0.014-inch DCB, CE Mark
News | Drug-Eluting Balloons| December 06, 2016
December 6, 2016 — The Spectranetics Corp.
TCT 2016, TCT.16, main arena, late breaking trials, transcatheter cardiovascular therapeutics

There were several hot topics that came out of the 2016 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting Oct. 29 - Nov. 2, which made this month's top 20 list, including several videos. Number 4 on the list of content was the result of the EXCEL Trial key TCT late-breaker, which showed stenting is equal in outcomes to surgery for the first time, when using one of the latest generation drug-eluting stents. 

Feature | December 05, 2016
December 5, 2016 — Here is the list of the top 20 most popular pieces of content on the Diagnostic and Interventional
Cardioband, valtech, Edwards Lifesciences, transcatheter mitral repair, transcatheter tricuspid valve repair, transcatheter annuloplasty

An illustration of how the transcatheter Cardioband System can used as a non-surgical form on annuloplasty repair. 

News | Heart Valve Technology| December 02, 2016
December 2, 2016 — Edwards Lifesciences Corp.
Sponsored Content | Videos | Robotic Systems| November 22, 2016
Corindus Vascular Robotics received U.S.
Overlay Init